Company Description
PathoGenesis Corporation. The principal activities of the Group are the development of drugs to treat chronic infectious diseases where there is a significant need for improved therapy; the market of TOBI (tobramycin solution for inhalation), an ...
More
Related Business Topics
Breaking News
Reuters - November 13, 2009 10:30 AM
DUBLIN--(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/fccd5e/pathology_at_a_gla) has announced the addition of John Wiley and Sons Ltd's new report 'Pathology at a Glance' to their offering. Following the familiar, ...
Forbes.com - November 13, 2009 9:53 AM
BusinessWire - Research and Markets (http://www.researchandmarkets.com/research/fccd5e/pathology_at_a_gla) has announced the addition of John Wiley and Sons Ltd's new report "Pathology at a Glance" to their offering. Following the familiar, easy-to-use ...
Reuters - November 11, 2009 1:48 PM
Round to fund phase 2a clinical trials for lead candidate AIR645, advance R&D SAN DIEGO--(Business Wire)-- Altair Therapeutics, Inc., a privately-held, biopharmaceutical company developing novel therapeutics for respiratory diseases, today announced that ...
Reuters - November 11, 2009 5:33 AM
DUBLIN--(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/21e153/competitor_analysi) has announced the addition of the 'Competitor Analysis: TGF-R Agonists and Antagonists' report to their offering. The present ...
Forbes.com - November 11, 2009 4:40 AM
BusinessWire - Research and Markets (http://www.researchandmarkets.com/research/21e153/competitor_analysi) has announced the addition of the "Competitor Analysis: TGF-R Agonists and Antagonists" report to their offering. The present Competitive ...
